Therapeutic regimens for treating psoriatic arthritis with an anti-ccl20 antibody
作者： Leigh Michael Felton , Stefano Zamuner , Michael James Herdman , Ruth Margaret Tarzi
DOI:
关键词:
摘要: The invention provides therapeutic regimens for inflammatory conditions (e.g psoriatic arthritis, Behcet's disease, and bowel diseases such as ulcerative colitis Crohn's disease) using anti-CCL20 antibodies, uses antibodies preparation of medicaments the conditions.
lens.org 参考文章(5)
Elvin A. Kabat, Sequences of proteins of immunological interest National Institutes of Health. ,(1991)
Tatsuo Horizoe, Jared Spidel, Kenzo Muramoto, Miyuki Nishimura, James Bradford Kline, Toshio Imai, Tetsu Kawano, Yoshimasa Sakamoto, Luigi Grasso, Neutralizing anti-ccl20 antibodies ,(2011)
Cyrus Chothia, Arthur M. Lesk, Canonical structures for the hypervariable regions of immunoglobulins Journal of Molecular Biology. ,vol. 196, pp. 901- 917 ,(1987) , 10.1016/0022-2836(87)90412-8
Laura J. Savage, Miriam Wittmann, Dennis McGonagle, Philip S. Helliwell, Ustekinumab in the Treatment of Psoriasis and Psoriatic Arthritis Rheumatology and Therapy. ,vol. 2, pp. 1- 16 ,(2015) , 10.1007/S40744-015-0010-2
Raquel Celis, Núria Planell, José L Fernández-Sueiro, Raimon Sanmartí, Julio Ramírez, Isidoro González-Álvaro, José L Pablos, Juan D Cañete, Synovial cytokine expression in psoriatic arthritis and associations with lymphoid neogenesis and clinical features. Arthritis Research & Therapy. ,vol. 14, pp. 1- 9 ,(2012) , 10.1186/AR3817